Literature DB >> 8073449

Patient preferences for stroke outcomes.

N A Solomon1, H A Glick, C J Russo, J Lee, K A Schulman.   

Abstract

BACKGROUND AND
PURPOSE: In clinical trials stroke is reported as a major morbid outcome, but the impact of stroke on patients is not directly assessed. This study examines patient preferences for different outcomes of stroke, including death.
METHODS: We presented patients with written case scenarios of stroke outcomes. The scenarios represented four categories of stroke severity (mild, moderate, severe, and fatal), and for nonfatal strokes the scenarios described motor, language, and cognitive deficits. Patients reported values for each of the 10 stroke scenarios using a rank-and-scale method over a 100-point range, with 100 representing perfect health and 0 corresponding to the worst possible health state.
RESULTS: One hundred seventeen of 209 consecutive patients at risk for stroke participated in this study. Severe strokes were uniformly rated as having low preference weights (mean +/- SD [median]: 3 +/- 4 [1] for disabling hemiplegia, 8 +/- 9 [5] for confusion, and 15 +/- 14 [10] for global aphasia), and severe motor impairment (a disabling hemiplegia) was rated as significantly worse than death. Even mild deficits resulted in substantial loss to patients (54 +/- 21 [55] for dysarthria and 53 +/- 21 [50] for mild anomia).
CONCLUSIONS: Strokes may result in a wide variety of post-stroke consequences for patients. Severe strokes may be viewed by patients as tantamount to or worse than death. Even mild strokes may cause significant declines in patient preferences for health states. These data are useful in interpreting studies that report stroke and death, in designing new studies that measure stroke in at-risk populations, and in helping patients reach treatment decisions about therapies designed to prevent strokes.

Entities:  

Mesh:

Year:  1994        PMID: 8073449     DOI: 10.1161/01.str.25.9.1721

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  34 in total

Review 1.  Intracranial hemorrhage.

Authors:  Andrew M Naidech
Journal:  Am J Respir Crit Care Med       Date:  2011-11-01       Impact factor: 21.405

2.  A meta-analysis of quality-of-life estimates for stroke.

Authors:  Tammy O Tengs; Ting H Lin
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

3.  Stroke Performance Measures Do Not Predict Functional Outcome.

Authors:  Eric E Adelman; Lynda D Lisabeth; Melinda A Smith; Jonggyu Baek; Erin C Case; Brisa N Sánchez; James F Burke; Lesli E Skolarus; Darin B Zahuranec; William J Meurer; Devin L Brown; Kevin A Kerber; Deborah A Levine; Nelda M Garcia; Morgan S Campbell; Lewis B Morgenstern
Journal:  Neurohospitalist       Date:  2016-10-26

4.  Ethical aspects of determining and communicating prognosis in critical care.

Authors:  James L Bernat
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

5.  Atrial fibrillation--the growing epidemic.

Authors:  Gregory Y H Lip; Puneet Kakar; Timothy Watson
Journal:  Heart       Date:  2007-05       Impact factor: 5.994

6.  Marginally effective medical care: ethical analysis of issues in cardiopulmonary resuscitation (CPR)

Authors:  M Hilberman; J Kutner; D Parsons; D J Murphy
Journal:  J Med Ethics       Date:  1997-12       Impact factor: 2.903

Review 7.  Thrombolytic treatment for acute ischaemic stroke: consent can be ethical.

Authors:  R I Lindley
Journal:  BMJ       Date:  1998-03-28

8.  Assessment of post-stroke quality of life in cost-effectiveness studies: the usefulness of the Barthel Index and the EuroQoL-5D.

Authors:  N J A van Exel; W J M Scholte op Reimer; M A Koopmanschap
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

9.  Competing cardiovascular outcomes associated with subclinical atherosclerosis (from the Multi-Ethnic Study of Atherosclerosis).

Authors:  Chintan S Desai; Hongyan Ning; Joseph Kang; Aaron R Folsom; Joseph F Polak; Christopher T Sibley; Russell Tracy; Donald M Lloyd-Jones
Journal:  Am J Cardiol       Date:  2013-03-15       Impact factor: 2.778

Review 10.  The medical economics of stroke.

Authors:  T N Taylor
Journal:  Drugs       Date:  1997       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.